Multiple myeloma.
作者信息
Rajkumar S Vincent
出版信息
Curr Probl Cancer. 2009 Jan-Feb;33(1):7-64. doi: 10.1016/j.currproblcancer.2009.01.001.
Abstract
摘要
相似文献
1
Multiple myeloma.多发性骨髓瘤
Curr Probl Cancer. 2009 Jan-Feb;33(1):7-64. doi: 10.1016/j.currproblcancer.2009.01.001.
2
Hematology: Setting the standard for newly diagnosed multiple myeloma.
Nat Rev Clin Oncol. 2011 May;8(5):255-6. doi: 10.1038/nrclinonc.2011.43. Epub 2011 Mar 22.
3
[Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].日本骨髓瘤研究组多发性骨髓瘤诊断与管理指南
Rinsho Ketsueki. 2005 Jun;46(6):424-32.
4
Promising therapies in multiple myeloma.多发性骨髓瘤的潜在治疗方法。
Blood. 2015 Jul 16;126(3):300-10. doi: 10.1182/blood-2015-03-575365. Epub 2015 Jun 1.
5
Emerging therapies for multiple myeloma.多发性骨髓瘤的新兴疗法。
Oncology (Williston Park). 2009 Apr 30;23(5):407-15.
6
Myeloma and the newly diagnosed patient: a focus on treatment and management.骨髓瘤与新确诊患者：聚焦治疗与管理
Semin Oncol. 2002 Dec;29(6 Suppl 17):5-10. doi: 10.1053/sonc.2002.34070.
7
Maintenance therapy and supportive care for patients with multiple myeloma.多发性骨髓瘤患者的维持治疗和支持性护理。
Semin Oncol. 1999 Oct;26(5 Suppl 13):35-42.
8
Treatment of newly diagnosed multiple myeloma.初诊多发性骨髓瘤的治疗。
Curr Hematol Malig Rep. 2008 Apr;3(2):107-14. doi: 10.1007/s11899-008-0016-8.
9
Updates to the guidelines for the diagnosis and management of multiple myeloma.多发性骨髓瘤诊断与管理指南的更新
Br J Haematol. 2014 Oct;167(1):131-3. doi: 10.1111/bjh.12926. Epub 2014 May 7.
10
The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials.大多数新诊断的骨髓瘤患者不符合III期临床试验的纳入标准。
Leukemia. 2019 Feb;33(2):546-549. doi: 10.1038/s41375-018-0272-0. Epub 2018 Sep 28.
引用本文的文献
1
Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic Options.多发性骨髓瘤：治疗选择数量迅速增加带来的预后改善
Target Oncol. 2025 Mar;20(2):247-267. doi: 10.1007/s11523-024-01122-4. Epub 2025 Jan 29.
2
Targeting B-cell maturation antigen for treatment and monitoring of relapsed/refractory multiple myeloma patients: a comprehensive review.靶向B细胞成熟抗原用于复发/难治性多发性骨髓瘤患者的治疗与监测：综述
Ther Adv Hematol. 2024 Sep 14;15:20406207241275797. doi: 10.1177/20406207241275797. eCollection 2024.
3
Osteosclerotic Multiple Myeloma without POEMS Syndrome - A Rare Case Report.无POEMS综合征的骨硬化性多发性骨髓瘤——1例罕见病例报告
J Orthop Case Rep. 2022 Jan;12(1):18-21. doi: 10.13107/jocr.2022.v12.i01.2598.
4
Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review).对 SUMOylation 通路在血液系统恶性肿瘤中影响的新认识（综述）。
Int J Oncol. 2021 Sep;59(3). doi: 10.3892/ijo.2021.5253. Epub 2021 Aug 9.
5
Therapeutic Advances in Oncology.肿瘤治疗进展
Int J Mol Sci. 2021 Feb 18;22(4):2008. doi: 10.3390/ijms22042008.
6
Hyperammonemic Encephalopathy: A Unique Presentation of Multiple Myeloma.高氨血症性脑病：多发性骨髓瘤的一种独特表现。
Cureus. 2021 Jan 19;13(1):e12781. doi: 10.7759/cureus.12781.
7
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel ()-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents.探索RC-106化学空间：新型（）-1-（3-芳基丁-2-烯-1-基）-4-（取代）哌嗪衍生物作为潜在抗癌剂的设计与合成
Front Chem. 2020 Jun 30;8:495. doi: 10.3389/fchem.2020.00495. eCollection 2020.
8
comparison of the cytotoxic effects of statins on U266 myeloma cell line.比较他汀类药物对 U266 骨髓瘤细胞系的细胞毒性作用。
Indian J Med Res. 2019 Dec;150(6):630-634. doi: 10.4103/ijmr.IJMR_672_18.
9
GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma.BL-8040 联合 G-CSF 动员造血细胞进行骨髓瘤自体移植的 III 期临床试验。
Future Oncol. 2019 Nov;15(31):3555-3563. doi: 10.2217/fon-2019-0380. Epub 2019 Sep 9.
10
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.血清游离轻链升高与慢性淋巴细胞白血病和单克隆 B 细胞淋巴增生症的关系。
Blood Cancer J. 2019 Aug 5;9(8):59. doi: 10.1038/s41408-019-0220-x.
本文引用的文献
1
Case of Mollities and Fragilitas Ossium, accompanied with urine strongly charged with animal matter.骨质软化与脆弱症病例，伴有尿液中含有大量动物性物质。
Med Chir Trans. 1850;33:211-32. doi: 10.1177/095952875003300113.
2
Remarks on the pathology of mollities ossium; with cases.骨质软化症病理学述评；附病例
Med Chir Trans. 1844;27:435-498.8. doi: 10.1177/095952874402700129.
3
Urethane and stilbamidine in multiple myeloma report on two cases.关于两例多发性骨髓瘤患者使用氨基甲酸乙酯和戊烷脒的报告。
Lancet. 1947 Sep 13;2(6472):388. doi: 10.1016/s0140-6736(47)90375-9.
4
ELECTROPHORETIC PATTERNS OF NORMAL AND PATHOLOGICAL HUMAN BLOOD SERUM AND PLASMA.正常人和病理性人血清和血浆的电泳图谱。
J Exp Med. 1939 Sep 30;70(4):399-413. doi: 10.1084/jem.70.4.399.
5
AN ELECTROPHORETIC STUDY OF IMMUNE SERA AND PURIFIED ANTIBODY PREPARATIONS.免疫血清和纯化抗体制剂的电泳研究。
J Exp Med. 1939 Jan 1;69(1):119-31. doi: 10.1084/jem.69.1.119.
6
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.硼替佐米联合美法仑和泼尼松用于多发性骨髓瘤的初始治疗。
N Engl J Med. 2008 Aug 28;359(9):906-17. doi: 10.1056/NEJMoa0801479.
7
A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma.一项比较唑来膦酸与观察等待对无症状骨髓瘤患者疗效的多中心随机临床试验。
Cancer. 2008 Oct 1;113(7):1588-95. doi: 10.1002/cncr.23783.
8
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.一项关于新诊断多发性骨髓瘤患者串联自体移植与自体移植后接受低强度预处理异基因移植的前瞻性PETHEMA研究。
Blood. 2008 Nov 1;112(9):3591-3. doi: 10.1182/blood-2008-02-141598. Epub 2008 Jul 8.
9
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.口服美法仑、泼尼松和沙利度胺用于老年多发性骨髓瘤患者：一项随机对照试验的更新结果
Blood. 2008 Oct 15;112(8):3107-14. doi: 10.1182/blood-2008-04-149427. Epub 2008 May 27.
10
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma.沙利度胺联合地塞米松与地塞米松作为新诊断多发性骨髓瘤初始治疗的多中心、随机、双盲、安慰剂对照研究
J Clin Oncol. 2008 May 1;26(13):2171-7. doi: 10.1200/JCO.2007.14.1853. Epub 2008 Mar 24.
Zotero 插件